Covid-19
Brazil
Sinovac’s COVID-19 Vaccine Over 50% Effective, Reports Newspaper Folha
·
December 23, 2020
·
1 min read
RIO DE JANEIRO, BRAZIL – Sinovac Biotech’s vaccine against COVID-19 is over 50% effective in late-stage trials, newspaper Folha de S. Paulo reported on Wednesday, December 23rd, adding that the Chinese company had asked the Brazilian institute running tests to wait up to 15 days before publishing their full results.
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →The Butantan Institute, which is running the trial in Brazil, and the government of São Paulo, which oversees the institute, declined to comment, saying there would be more details in a news conference at 4 p.m. local time.
More: Brazil news in English, every day from The Rio Times.
Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error
Read next
Most read in BrazilBrazil Election 2026: Lula Leads First Round, Runoff a Dead Heat in Final AtlasIntel PollMost read in BrazilBrazil Votes on Sunday: Hours, Alcohol Rules and What Expats Need to KnowIn depth · BrazilBrazil Leads Latin America Election Supercycle as Lula and Flávio Bolsonaro Face October VoteThe Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →